| Extracellular Matrix and Adhesion Molecules L Hayrapetyan, N Sarvazyan Tissue Engineering: Principles, Protocols, and Practical Exercises, 29-38, 2020 | 4 | 2020 |
| Comparison of articular and auricular cartilages: decellularization, cell proliferation rate, and infiltration in scaffolds L Hayrapetyan, H Arestakesyan, A Margaryan, A Oganesyan, V Grigoryan, ... Research on Biomedical Engineering 37, 193-200, 2021 | 2 | 2021 |
| Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies K Yenkoyan, Z Ounanian, M Mirumyan, L Hayrapetyan, N Zakaryan, ... Current medicinal chemistry 31 (12), 1485-1511, 2024 | | 2024 |
| Mice lacking a novel phosphosite S1014 on the MET receptor tyrosine kinase display ASD-associated behavioral pattern L Hayrapetyan, S Bouteiller, A Quintin, R Riedo, P Degen, D Aebersold, ... IBRO Neuroscience Reports, 2023 | | 2023 |
| A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response JP Koch, SM Roth, A Quintin, J Gavini, E Orlando, R Riedo, C Pozzato, ... Oncogene 42 (26), 2113-2125, 2023 | | 2023 |
| p53-dependent treatment response to DNA-PK inhibition in combination with irradiation in head and neck squamous cell carcinoma (HNSCC) models L Hayrapetyan, SM Roth, L Hovhannisyan, M Medo, DM Aebersold, ... Cancer Research 83 (7_Supplement), 498-498, 2023 | | 2023 |
| A newly discovered phosphorylation site of the MET receptor tyrosine kinase, Ser1016, in mediating tumour growth and cancer therapy resistance. C Pozzato, JP Koch, R Riedo, L Hayrapetyan, M Medo, DM Aebersold, ... | | 2023 |
| Sex-and strain-dependent dominant behavior in mice lacking the novel S1014 phosphosite on the ASD risk gene MET. L Hayrapetyan, PM Degen, S Bouteiller, R Riedo, A Quintin, ... | | 2023 |
| Characterization of predictive power of extracellular signal recordings in a cerebral ischemia animal model S Matinyan, L Hovhannisyan, A Hakobyan, A Khamperyan, ... bioRxiv, 2023.05. 19.541417, 2023 | | 2023 |
| HPV and p53 status as precision determinants of head and neck cancer response to DNA-PKcs inhibition in combination with irradiation L Hayrapetyan, SM Roth, L Hovhannisyan, M Medo, A Quintin, J Ott, ... bioRxiv, 2023.11. 02.565300, 2023 | | 2023 |
| Alopecia Areata as a Side Effect of Immune Checkpoint Inhibitor Pembrolizumab in a Patient with Advanced Non-Small Cell Lung Cancer A Oganesyan, L Hayrapetyan TP139. TP139 THORACIC ONCOLOGY: CASE REPORTS-NON-SMALL CELL LUNG CANCER …, 2021 | | 2021 |
